Sphere 3D Corp
Change company Symbol lookup
Select an option...
ANY Sphere 3D Corp
HMY Harmony Gold Mining Company Ltd
PLX Protalix Biotherapeutics Inc
BEDU Bright Scholar Education Holdings Ltd
USAS Americas Gold and Silver Corporation
AA Alcoa Corp
CRIS Curis Inc
APTO Aptose Biosciences Inc
RGLS Regulus Therapeutics Inc
IMH Impac Mortgage Holdings Inc
Go

Information Technology : Software | Small Cap Value
Based in Canada
Company profile

Sphere 3D Corp is a Canada-based company engaged in software development sector. The Company delivers data management, desktop and application virtualization solutions through hybrid cloud, cloud and on premise implementations by its global reseller network. The Company achieves this through a combination of containerized applications, virtual desktops, virtual storage and physical hyper-converged platforms. The Company’s products allow organizations to deploy a combination of public, private or hybrid cloud strategies while backing them up with the latest storage solutions. The Company has a portfolio of brands including RDX, Glassware 2.0, SnapCLOUD, SnapServer, SnapSync, NEO and V3 .

Closing Price
$2.68
Day's Change
-0.53 (-16.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.18
Day's Low
2.40
Volume
(Below Average)
Volume:
19,187,377

10-day average volume:
23,615,748
19,187,377

LFMD, FUV & ACAD Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm

11:02 am ET May 4, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 4, 2021 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

LifeMD, Inc. (NASDAQ:LFMD)Class Period: January 19, 2021 - April 13, 2021Deadline: June 15, 2021|For more info: www.bgandg.com/lfmd.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) many of LifeMD's executives were associated with Redwood Scientific when it was charged for unlawful autoshipping, abusive telemarketing, and false claims, and that they employed similar practices at the Company; (2) LifeMD engaged in autoshipping products to unwilling customers to record recurring revenue and the Company made it difficult to cancel such subscriptions; (3) certain of the purportedly licensed physicians on the Company's platform were not in fact licensed and faced disciplinary action; (4) as a result of the foregoing practices, the Company was reasonably likely to face regulatory scrutiny and/or reputational harm; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Arcimoto, Inc. (NASDAQ:FUV)Class Period: February 14, 2018 - March 22, 2021Deadline: June 18, 2021For more info: www.bgandg.com/fuv.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) the preorders of Arcimoto's Fun Utility Vehicles ("FUVs") were fabricated or never completed, with only 19 units delivered out of an alleged preorder of 422; (2) Arcimoto failed to disclose to customers that nearly 100% of its vehicles delivered were under safety recall; (3) Arcimoto's largest customer, R-Key-Moto, was an undisclosed related party owned by insider FOD Capital, LLC; (4) Arcimoto's partnership with HULA was an undisclosed related party transaction; and (5) as a result, defendants' public statements were materially false and/or misleading at all relevant times.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)Class Period: June 15, 2020 - April 4, 2021Deadline: June 18, 2021For more info: www.bgandg.com/acad.

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose that: (1) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (2) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (3) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLCPeretz Bronstein or Yael Hurwitz212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

View source version on accesswire.com: https://www.accesswire.com/643740/LFMD-FUV-ACAD-Reminders-Bronstein-Gewirtz-Grossman-LLC-Reminds-Shareholders-of-Class-Actions-and-Encourages-Investors-to-Contact-the-Firm

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.